Pfizer applies to U.S. for booster shots of upgraded new crown vaccine for children aged 5 to 11

　　China News Service, September 27. According to foreign media reports, American Pfizer and German pharmaceutical company BioNTech submitted to the US Food and Drug Administration (FDA) on the 26th local time to vaccinate children aged 5 to 11 years. Needle application authorization.

　　According to the National Public Radio (NPR) of the United States, this new generation of new crown vaccine booster can simultaneously fight against the original strain of the new crown and the two subtype strains of Omicron BA.4 and BA.5. 90% of confirmed cases are infected with these two Omicron variant strains.

　　Pfizer and BioNTech also plan to submit applications to the European Medicines Agency.

　　It is reported that on August 31, local time, the U.S. Food and Drug Administration has approved the upgraded version of the new crown vaccine of Moderna and Pfizer against the Omicron strain.

The upgraded version of the Moderna vaccine is suitable for people 18 years of age and older, and the upgraded version of the Pfizer vaccine is suitable for people 12 years of age and older.

　　According to the latest statistics from Johns Hopkins University in the United States, as of 12:00 on the 27th, the cumulative number of confirmed cases of new crowns in the United States exceeded 96.11 million, and the number of deaths exceeded 1.056 million.